Braidwell’s Elevance Health ELV Stock Holding History

Braidwell’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.9M	Sell	53,960 -8,120	-13%	-$3.01M	0.77%	52
2026 Q1	$18.2M	Buy	+62,080	New	+$20.4M	0.61%	58

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Braidwell's ELV Position: Q2 2026 in Review

Braidwell reduced its Elevance Health (ELV) stake by 13% in Q2 2026, selling an estimated $3.01M and leaving 53,960 shares worth $20.9M. The position accounts for 0.77% of the portfolio, ranked #52.

Braidwell first reported a position in ELV in Q1 2026 and has held it in 2 quarters since. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Braidwell held 53,960 shares of Elevance Health worth $20.9M as of Q2 2026.
Braidwell sold 8,120 Elevance Health shares in Q2 2026, an estimated $3.01M.
Elevance Health made up 0.77% of Braidwell's portfolio in Q2 2026, its #52 holding.
Braidwell first reported a position in Elevance Health in Q1 2026 and has held it in 2 quarters since.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.